An updated systematic search and review of published information from over 4,000 malaria samples has identified areas in central, eastern and north-eastern India where treatment-resistant malaria parasites could be more prevalent.

New work from the Medicine Quality Group at IDDO and MORU pilots the use of stable isotope mass spectrometry to estimate where falsified antimalarials and their components come from. The study, published in Scientific Reports, is a collaboration between the Medicine Quality Research Group, LOMWRU, a...

Widely available rapid diagnostic tests (RDTs) manufactured to diagnose common infections can be repurposed to detect substandard and falsified (SF) vaccines, a neglected issue with serious global implications for public health, say researchers in a study published in Vaccine.

IDDO’s Medicine Quality Research Group (MQRG) have written a chapter in a new book which examines the global issue of substandard and falsified medical products.

The FORESFA project's laboratory group met for a workshop in Trentino, Italy, with participants from Oxford, Edinburgh, London, and Vienna. The workshop focused on advancing the analysis of simulated samples, which are crucial to developing forensic techniques to analyse falsified medical products. ...

A systematic review and individual patient meta-analysis found that malaria chemoprevention after hospital discharge reduces deaths in children recovering from severe anaemia by 70%, and hospital readmission by 55%.

A new study estimates that nearly 1 in 4 people with P. falciparum malaria in Africa are at risk of receiving too low a dose of artemisinin combination therapies (ACTs), increasing the chance of treatment failure and the risk that malarial parasites develop resistance to the drug they were exposed t...

A meta-analysis of nearly 30,000 patients suggests that a post-treatment follow-up duration of longer than 6-months may be needed to identify visceral leishmaniasis relapses.

The WorldWide Antimalarial Research Network’s (WWARN) website has a new home and now sits within the Infectious Diseases Data Observatory portfolio of research themes.

Professor Paul Newton, head of IDDO’s Medicine Quality Research Group has received an ‘Excellent Supervisor’ award.

IDDO and WWARN are delighted to be taking part in this year’s 13th European Congress on Tropical Medicine and International Health, (ECTMIH), and will be sharing our latest research across visceral leishmaniasis, malaria, medicine quality and lymphatic filariasis.

IDDO is part of a coalition of over 900 scientists calling for a fairer investment in infectious disease research in low resource areas

The WWARN Vivax adherence study group-led meta-analysis finds that poor adherence to primaquine treatment regimens increased recurrence by 2.3-fold.

A collaborative study by researchers from the Institut de Recherche en Sciences de La Santé of Nanoro (IRRS-Nanoro) in Burkina Faso and IDDO/WWARN has found that giving young children vitamin and lipid supplements at the same time as seasonal malaria chemoprevention reduces the incidence of severe ...

An international consortium of multidisciplinary researchers and specialists has developed a new method to counter the problem of COVID-19 vaccine falsification.

Professor Philippe Guérin, IDDO and WWARN’s Director, has been awarded the Bailey K. Ashford Medal for his “distinguished” work in tropical medicine.

Join IDDO and WWARN’s researchers at this year’s ASTMH - the 72nd annual meeting in Chicago, USA, where we will be presenting on Visceral Leishmaniasis, malaria, and medicine quality across symposia, oral presentations and posters.

Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in malaria endemic countries.